{"id":"NCT04414345","sponsor":"Merit E. Cudkowicz, MD","briefTitle":"HEALEY ALS Platform Trial - Regimen C CNM-Au8","officialTitle":"HEALEY ALS Platform Trial - Regimen C CNM-Au8","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2020-07-30","primaryCompletion":"2022-04-13","completion":"2023-03-07","firstPosted":"2020-06-04","resultsPosted":"2023-07-25","lastUpdate":"2023-07-25"},"enrollment":161,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Amyotrophic Lateral Sclerosis"],"interventions":[{"type":"DRUG","name":"CNM-Au8","otherNames":[]},{"type":"DRUG","name":"Matching Placebo","otherNames":[]}],"arms":[{"label":"CNM-Au8","type":"EXPERIMENTAL"},{"label":"Matching Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.\n\nRegimen C will evaluate the safety and efficacy of a single study drug, CNM-Au8, in participants with ALS.","primaryOutcome":{"measure":"Disease Progression as Assessed by the ALSFRS-R Total Score","timeFrame":"Baseline to 24 Weeks","effectByArm":[{"arm":"CNM-Au8","deltaMin":-1.01,"sd":0.075},{"arm":"Matching Placebo","deltaMin":-1.03,"sd":0.072}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["40067821"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":120},"commonTop":["Fall","Muscular weakness","Diarrhoea","Nausea","Fatigue"]}}